The Increasing Adoption Of Research Antibodies In Drug Discovery To Open Up New Avenue For The Research Antibodies Market

Research Antibodies Market


The Research Antibodies Market is estimated to be valued at US$ 3785.5 Bn or Mn in 2023 and is expected to exhibit a CAGR of 5.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Research antibodies are broadly used across various applications including proteomics, drug discovery, genomics and others. They help in identifying specific proteins and antibodies that play important roles in the physiological and pathological cellular processes. They are extensively used in research to detect, measure and purify proteins along with other cellular components. The common types of research antibodies include primary antibodies, secondary antibodies and isotype controls.

Market Dynamics:
Research antibodies market growth is driven by growing investments in biomedical research and rising focus on disease diagnosis and drug discovery. According to Pharmaceutical Research and Manufacturers of America (PhRMA), the U.S. biopharmaceutical companies invested over US$ 83 billion in the research and development of new medicines and vaccines in 2020. Growing funding in healthcare research has prompted pharmaceutical companies and research institutes to adopt more advanced technologies, thereby positively impacting the market growth. Moreover, rising prevalence of chronic diseases worldwide has accelerated the search for novel therapeutic targets and drug development processes, which involves use of antibodies for screening purposes. According to World Health Organization (WHO), chronic diseases accounted for approximately 60% of all deaths globally in 2020. This has increased the demand for research tools like antibodies in drug discovery and development activities.

Market Dynamics:
Growing investments in biomedical research and rising focus on disease diagnosis and drug discovery are the major market drivers. According to Pharmaceutical Research
Segment Analysis
The research antibodies market is dominated by the primary antibodies segment, which holds over 60% share of the total market. Primary antibodies are directly labeled or unlabeled and play a crucial role in various research applications such as western blotting, immunofluorescence, immunohistochemistry, immunoprecipitation etc. owing to their high specificity and affinity towards target antigens. The major factor attributed to the large share of this segment is the wide application of primary antibodies in various research procedures.

PEST Analysis
Political: Government fundings and grants for research activities have influenced the growth of this market. Various initiatives focusing on advancing healthcare and drug development support the demand.
Economic: Rising research expenditure from pharmaceutical and biotechnology companies along with increased funding for healthcare has propelled the market growth.
Social: Growing awareness about disease diagnosis and increasing incidence of chronic diseases have fueled research activities, augmenting demand.
Technological: Developments in epitope tagging, humanization of antibodies and antibody engineering have widened the scope of applications and driven the market.

Key Takeaways
Global Research Antibodies Market Size is expected to witness high growth, exhibiting CAGR of 5.9% over the forecast period, due to increasing research activities in drug discovery and precision medicine.

The North America region dominates the research antibodies market and is expected to retain its dominance over the forecast period. This can be attributed to presence of large number of pharmaceutical & biotechnology companies and CROs in the region along with rising healthcare expenditure.

Key players operating in the research antibodies market are Thermo Fisher Scientific Inc, Bio-rad Laboratories, Lonza Group, Merck Millipore, Cell Signalling Technology Inc., F.Hoffmann La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company, Agilent Technologies, Danaher Corporation, BioLegend Inc., Illumina, Phoenix Pharmaceuticals, Abcam plc. These players are focusing on new product launches, expansions and collaborations to gain significant market share. 

Comments

Post a Comment

Popular posts from this blog

Security Robot Market is Estimated To Witness High Growth Owing To Increasing Demand for Enhanced Surveillance

Image
Security Robot Market The Security Robot Market is estimated to be valued at US$ 11.8 billion in 2022 and is expected to exhibit a CAGR of 12.87% over the forecast period of 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Overview: The Security Robot Market encompasses advanced robotic technologies that are specifically designed and developed to enhance security and surveillance operations. These robots are equipped with features such as video surveillance, thermal imaging, facial recognition, and intrusion detection, among others. They are extensively used by security agencies and organizations across various sectors, including residential, commercial, industrial, and government, to enhance safety, reduce human intervention, and streamline security operations. Security robots offer real-time monitoring, remote control, and high accuracy, making them an ideal choice for surveillance in sensitive areas and remote locations. Market Dynamics:
Read more

The Global Methyl & Ethyl Chloroacetate Market Is Expected To Register A Cagr Of 7.9% In Terms Of Revenue Over The Forecast Period (2019-2027)

Image
  Methyl chloroacetate is a colourless liquid with a pungent odour that is used as a dyestuff, medicine, and pesticide intermediate. Methyl chloroacetate has several advantages, including a precise pH value, excellent purity, precise composition, and a longer shelf life. Ethyl chloroacetate is a clear liquid with a strong, fruity odour that is used in the production of dyes, chemical compounds, and other products. Ethyl chloroacetate's benefits include a balanced composition, stable chemical and physical properties, and optimum purity.   The global methyl & ethyl chloroacetate market was valued at US$ 760.6 Mn in 2018, and is expected to register a CAGR of 7.9% in terms of revenue over the forecast period (2019-2027), to reach US$ 1,562.8 Mn by 2027.   Over the forecast period, the global Methyl & Ethyl Chloroacetate Market is expected to grow significantly. The various benefits offered by methyl and ethyl chloroacetate have led to an increase in their use in end-use indus
Read more

The Ever-Evolving Landscape of the Scottish Whisky Market during the Forecast Period 2019-2027

Image
  Scottish Whisky Market The Scottish Whisky Market is a captivating landscape that has been evolving and transforming over the years. It is a world of tradition, craftsmanship, and heritage, where every drop of whisky tells a story. The history of Scottish whisky traces back centuries, with the earliest records dating back to the 15th century. Whisky production initially started in monasteries, where monks distilled spirits for medicinal purposes. Over time, whisky production moved from monastic settings to farms and then to commercial distilleries. This transition marked the beginning of an industry that would become synonymous with Scotland. Scottish Whisky Market Was Valued At US$ 4.97 Bn In 2018, And It Is Expected To Reach US$ 7.89 Bn By The End Of 2027, Exhibiting A CAGR Of 5.3% During The Forecast Period (2019 To 2027). One of the defining characteristics of the Scottish Whisky Market is its adherence to traditional production methods. Scotch whisky is made from malted b
Read more